Content was king at Lab Innovations 2016. When the show closed its doors on Thursday it had delivered over 20 hours of educational content including seminar programmes from Campden BRI, NetComposites, the Science Council and the Royal Society of Chemistry.
The show, which is the UK’s only event for laboratory professionals, also featured over 40 product or company launches plus two days of Live Lab demonstrations. Matt Benyon, Managing Director of Easyfairs, Lab Innovations organisers, commented: “The show once again proved it’s the must-attend event for the laboratory industry. We had more launches, new ideas and concepts live on the showfloor than ever before....
Read MoreDomain Therapeutics and Medicxi launch Mavalon Therapeutics, Aimed at Halting the Progression of ParkinsonNov 7, 2016
Medicxi will invest up to €9m ($10m) in the asset-centric company to show clinical efficacy of Mavalon’s GDNF-inducer drug candidate, an mGluR3 PAM molecule discovered by Domain Therapeutics.
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson’s disease. Medicxi, a venture fund dedicated to financing asset-centric companies, has committed up to €9m ($10m) in Mavalon. Over the past two decades, biotech companies and clinicians have tried to...
Horizon announces new bioproduction outlicense deal with a minimum value of £500,000
Novel licensing model allows early access over a 5 year period to bioproduction cell line innovations as well as for immediate use of Horizon’s GS Null CHO K1 bioproduction cell line for drug manufacturing. Horizon Discovery Group plc (LSE: HZD), the world leader in the application of gene editing technologies, announces a new licensing agreement with an unnamed commercial partner for access to Horizon bioproduction cell lines....
This year's MicroTAS Video Competition has been won by Enrica Rollo from EPFL (École polytechnique fédérale de Lausanne) in Switzerland, for her entertaining comparison between cleanrooms and kitchens.
The annual competition – run by microfluidics specialist Dolomite and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society – embraces the lighter side of life sciences and chemistry, while giving delegates a chance to win €2,500 worth of Dolomite microfluidics equipment. Enrica's winning entry was a recipe for a 'Micropillars Chocolate Cake', providing an imaginative yet informative explanation of how micropillar electrodes...
Hookipa Biotech AG announces the award of a fifth major grant from the Austrian Research Promotion Agency (Forschungs-Förderungs-Gesellschaft, FFG), the leading public funding agency for translational research in Austria.
A EUR 4.16 million grant has been awarded for the second year of a multi-year research and development project. The grant will be used to further substantiate the broad applicability of Hookipa’s arenaviral vector technologies for the development of innovative cancer immunotherapies and to progress the development of Hookipa’s lead oncology product HB201 for the treatment of HPV...
BioHub at Alderley Park, operated on behalf of Manchester Science Partnerships by life science incubation specialist, The BioCity Group, has been named as "Best UK Life Science Incubator" at the OBN Awards.
The OBN Awards celebrate innovation and achievement across the UK life sciences Industry, with categories covering Biotech, Medtech, Synthetic Biology and Digital Health and recognise achievements from emerging to late stage R&D companies to large pharma and life sciences investors. Judges were asked to consider which incubator provides the best service to start-up and emerging companies....
Combined expertise will create best-in-class assay systems for drug potency, stability testing and other applications
ATCC, a global leader in biological materials development, management and standards, and BioAgilytix, a leading provider of contract testing services with a specialization in biologics, today announced a strategic partnership to develop new and custom cell-based assays to accelerate and enhance biopharmaceutical research and development. The partnership combines ATCC's deep expertise in developing, authenticating, banking, and provisioning cells with...
Test equipment specialist Testo Ltd. has supplied its latest temperature and humidity data logging system, Saveris 2, to Stansted Laboratories? facility in Barking, East London.
Stansted Laboratories is a highly successful UKAS accredited laboratory of 20 staff analysing over 50,000 samples a year in a purpose built facility. It specialises in microbiological analysis of water and air, with its main income derived from Legionella testing of water and drinking water bacteriological analysis....
Recipharm has announced a 5 million SEK investment into a new GLP (Good Laboratory Practice) compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response to growing customer demand.
The investment will see the opening of a 500 square metre purpose-built facility in November 2016, which will become the largest GLP bioanalysis laboratory of its kind in the Nordic countries. Recipharm’s development team in Uppsala specialises in medicinal chemistry, offering synthesis and analytical preclinical development services to drug development companies progressing products through clinical trials.....
Once again, Systec GmbH, the leading manufacturer of autoclaves, including laboratory autoclaves, media preparators, and plate pourers for liquid media and microbiological culture media, will be presenting the highlights of its comprehensive product range at this year’s Medica.
Advantages and special features of Systec autoclaves. Systec autoclaves can be used in all laboratory applications, including challenging sterilization processes: Sterilizing liquids (such as culture media, nutrient media), solid bodies (such as instruments, pipettes, glassware), waste (sterilization of liquid waste in bottles or solid waste in waste bags before destruction), and biologically hazardous materials in...
Porvair Sciences has confirmed that 2016 will see record sales of its Ultravap and Minivap ranges of blowdown evaporators to laboratories worldwide.
The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999. Offering unmatched ease of integration into robotic liquid handling workflows, the latest Porvair microprocessor controlled evaporators, the Ultravap Mistral and Ultravap Levante, has consolidated their position as a leading international supplier of microplate evaporators....
It’s a challenging time for UK plc as the country sets sail for a post-Brexit world but the South-East’s leading science and technology focused campus, Discovery Park is confident of a globally successful future.
Located in Sandwich and part of Dover district, this formerly Pfizer owned R&D hub has long seen itself as being inextricably linked to Europe, with France just a short hop across the English Channel. But initial uncertainty following the 23 June ballot over what this would mean for research funding and collaboration between the continent’s finest scientific minds has been replaced - for now at least – by a determination to seek out new opportunities, and to be ready for what comes next.
Particle Works – the nano- and microstructured material specialist – provides microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery.
Using its expertise in microfluidics and nanoparticle synthesis, the company can create bespoke PLGA formulations and coatings to alter drug release profiles, enhance the efficiency of targeted drug delivery and more precisely control dosing regimes. Microencapsulation of active pharmaceutical ingredients (APIs) is increasingly being employed in the drug development arena to improve the solubility of candidate drugs ....
Genomics plc, a leading analysis company developing an integrated platform to uncover the relationships between genetic variation and human disease, today announced that it has been appointed as Analysis Partner for the Genomics England Genomics Expert Network for Enterprises (GENE) Consortium.
Genomics plc will be analysing genomes at an unprecedented scale and, together with the Company’s existing knowledge base, be providing insights into human biology that will help to inform pharmaceutical R&D investment decisions. Genomics England is delivering the UK 100,000 Genomes Project – whole genome sequencing rare disease and cancer patients in the National Health Service....
Continuous success with innovative solutions for real-time trace VOC analysis since 1998.
IONICON Analytik, the Austrian based leading manufacturer of real-time trace VOC analyzers, based on the unique PTR-MS technology, has sold its 300th instrument. The analyzer, a PTR-TOF 1000 system, was shipped abroad in September 2016 and will be used for analyzing chemical pollutants in industrial areas. The whole IONICON team with currently more than 30 employees celebrates this achievement. Taking a look back. Everything started in...
Machine learning and advanced analytics help Healx identify new uses for existing drugs
Amadeus Capital Partners, the global technology investor, has made an early-stage investment in Healx, an innovative British healthcare company that seeks new uses for existing drugs in the fight against rare diseases. Amadeus Capital is investing in a £1.5 million Series A round, alongside renowned healthcare entrepreneur, Jonathan Milner....
CAMECA is pleased to announce the launch of the SKAPHIA Shielded Electron Probe Initiative, which brings together key players in the nuclear industry and nuclear research community to develop the next generation of shielded Electron Probe Microanalyzers (EPMA).
The initiative capitalizes on CAMECA’s more than years 50 years of experience in developing and servicing shielded microanalytical instruments for nuclear fuel characterization, irradiated materials behavior investigation, and radioactive waste management. CAMECA has had a great deal of success supporting the nuclear industry and scientific community, starting in 1978 with the installation of the first shielded electron probe microanalyzer...
SP Scientific has purchased ControLyo™ Nucleation Technology and all related patents from Praxair Inc. (Danbury, CT).
ControLyo™ nucleation technology controls the freezing stage of the freeze drying process for more consistent and repeatable outcomes that aid drug development, scale-up and production efforts. SP which manufactures a full range of research through production lyophilization equipment and technologies has had a licensing agreement with Praxair, Inc. to provide ControLyo™ technology as part of its portfolio since 2010...
Science World, the Fisher Scientific Laboratory Experience, made its successful launch in France at the Palais de la Musique et des Congrès in Strasbourg on 29 September.
The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through the Fisher Scientific channel. Thousands of products were available for attendees to experience, making it an ideal event for anyone working in or around a laboratory. Highlights from Science World included the well-known anthropologist Yves Coppens who presented a keynote speech....
The Royal Society of Chemistry (RSC) is returning to Lab Innovations 2016, the UK’s only event dedicated to laboratory professionals, to host a two-day conference in its own dedicated theatre.
The hotly anticipated conference programme, taking place at the NEC Birmingham on 2 & 3 November, will feature leading speakers from the laboratory industry who will take to the stage to discuss a series of key topics, including digital healthcare and elemental discovery. Alongside an array of inspiring seminars, the conference boasts keynote sessions from two internationally renowned figures, who have firmly made their mark on the laboratory industry...
Department moves into enhanced facility and increases headcount in response to continued demand for services
Quotient Clinical, the Translational Pharmaceutics® company, a leading provider of early stage and specialist drug development services, today announced the expansion of its Data Sciences function with relocation to a larger office, staying in Edinburgh. The expansion comes in response to growing customer demand for the Data Sciences service....
Clean, renewable energy is now powering BioTek Instruments!
The company’s headquarters and manufacturing plant in Winooski will receive power from their new five-acre photovoltaic solar energy farm in Whiting, Vermont. The solar farm has a maximum capacity of up to 500 kilowatts, and was designed and installed by Green Earth Energy...
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson’s disease. Medicxi, a venture fund dedicated to financing asset-centric companies, has committed up to €9m ($10m) in Mavalon. Over the past two decades, biotech companies and clinicians have tried to...
Novel licensing model allows early access over a 5 year period to bioproduction cell line innovations as well as for immediate use of Horizon’s GS Null CHO K1 bioproduction cell line for drug manufacturing. Horizon Discovery Group plc (LSE: HZD), the world leader in the application of gene editing technologies, announces a new licensing agreement with an unnamed commercial partner for access to Horizon bioproduction cell lines....
The annual competition – run by microfluidics specialist Dolomite and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society – embraces the lighter side of life sciences and chemistry, while giving delegates a chance to win €2,500 worth of Dolomite microfluidics equipment. Enrica's winning entry was a recipe for a 'Micropillars Chocolate Cake', providing an imaginative yet informative explanation of how micropillar electrodes...
A EUR 4.16 million grant has been awarded for the second year of a multi-year research and development project. The grant will be used to further substantiate the broad applicability of Hookipa’s arenaviral vector technologies for the development of innovative cancer immunotherapies and to progress the development of Hookipa’s lead oncology product HB201 for the treatment of HPV...
The OBN Awards celebrate innovation and achievement across the UK life sciences Industry, with categories covering Biotech, Medtech, Synthetic Biology and Digital Health and recognise achievements from emerging to late stage R&D companies to large pharma and life sciences investors. Judges were asked to consider which incubator provides the best service to start-up and emerging companies....
ATCC, a global leader in biological materials development, management and standards, and BioAgilytix, a leading provider of contract testing services with a specialization in biologics, today announced a strategic partnership to develop new and custom cell-based assays to accelerate and enhance biopharmaceutical research and development. The partnership combines ATCC's deep expertise in developing, authenticating, banking, and provisioning cells with...
Stansted Laboratories is a highly successful UKAS accredited laboratory of 20 staff analysing over 50,000 samples a year in a purpose built facility. It specialises in microbiological analysis of water and air, with its main income derived from Legionella testing of water and drinking water bacteriological analysis....
The investment will see the opening of a 500 square metre purpose-built facility in November 2016, which will become the largest GLP bioanalysis laboratory of its kind in the Nordic countries. Recipharm’s development team in Uppsala specialises in medicinal chemistry, offering synthesis and analytical preclinical development services to drug development companies progressing products through clinical trials.....
Advantages and special features of Systec autoclaves. Systec autoclaves can be used in all laboratory applications, including challenging sterilization processes: Sterilizing liquids (such as culture media, nutrient media), solid bodies (such as instruments, pipettes, glassware), waste (sterilization of liquid waste in bottles or solid waste in waste bags before destruction), and biologically hazardous materials in...
The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999. Offering unmatched ease of integration into robotic liquid handling workflows, the latest Porvair microprocessor controlled evaporators, the Ultravap Mistral and Ultravap Levante, has consolidated their position as a leading international supplier of microplate evaporators....
Using its expertise in microfluidics and nanoparticle synthesis, the company can create bespoke PLGA formulations and coatings to alter drug release profiles, enhance the efficiency of targeted drug delivery and more precisely control dosing regimes. Microencapsulation of active pharmaceutical ingredients (APIs) is increasingly being employed in the drug development arena to improve the solubility of candidate drugs ....
Genomics plc will be analysing genomes at an unprecedented scale and, together with the Company’s existing knowledge base, be providing insights into human biology that will help to inform pharmaceutical R&D investment decisions. Genomics England is delivering the UK 100,000 Genomes Project – whole genome sequencing rare disease and cancer patients in the National Health Service....
IONICON Analytik, the Austrian based leading manufacturer of real-time trace VOC analyzers, based on the unique PTR-MS technology, has sold its 300th instrument. The analyzer, a PTR-TOF 1000 system, was shipped abroad in September 2016 and will be used for analyzing chemical pollutants in industrial areas. The whole IONICON team with currently more than 30 employees celebrates this achievement. Taking a look back. Everything started in...
Amadeus Capital Partners, the global technology investor, has made an early-stage investment in Healx, an innovative British healthcare company that seeks new uses for existing drugs in the fight against rare diseases. Amadeus Capital is investing in a £1.5 million Series A round, alongside renowned healthcare entrepreneur, Jonathan Milner....
The initiative capitalizes on CAMECA’s more than years 50 years of experience in developing and servicing shielded microanalytical instruments for nuclear fuel characterization, irradiated materials behavior investigation, and radioactive waste management. CAMECA has had a great deal of success supporting the nuclear industry and scientific community, starting in 1978 with the installation of the first shielded electron probe microanalyzer...
ControLyo™ nucleation technology controls the freezing stage of the freeze drying process for more consistent and repeatable outcomes that aid drug development, scale-up and production efforts. SP which manufactures a full range of research through production lyophilization equipment and technologies has had a licensing agreement with Praxair, Inc. to provide ControLyo™ technology as part of its portfolio since 2010...
The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through the Fisher Scientific channel. Thousands of products were available for attendees to experience, making it an ideal event for anyone working in or around a laboratory. Highlights from Science World included the well-known anthropologist Yves Coppens who presented a keynote speech....
The hotly anticipated conference programme, taking place at the NEC Birmingham on 2 & 3 November, will feature leading speakers from the laboratory industry who will take to the stage to discuss a series of key topics, including digital healthcare and elemental discovery. Alongside an array of inspiring seminars, the conference boasts keynote sessions from two internationally renowned figures, who have firmly made their mark on the laboratory industry...
Quotient Clinical, the Translational Pharmaceutics® company, a leading provider of early stage and specialist drug development services, today announced the expansion of its Data Sciences function with relocation to a larger office, staying in Edinburgh. The expansion comes in response to growing customer demand for the Data Sciences service....
The company’s headquarters and manufacturing plant in Winooski will receive power from their new five-acre photovoltaic solar energy farm in Whiting, Vermont. The solar farm has a maximum capacity of up to 500 kilowatts, and was designed and installed by Green Earth Energy...